SELLAS Life Sciences Group Inc (SLS)
1.46
-0.01
(-0.68%)
USD |
NASDAQ |
May 17, 16:00
1.465
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.076M |
| June 30, 2018 | 7.779M |
| March 31, 2018 | 9.676M |
| December 31, 2017 | 10.99M |
| Date | Value |
|---|---|
| September 30, 2017 | 12.17M |
| June 30, 2017 | 13.02M |
| March 31, 2017 | 12.60M |
| December 31, 2016 | 7.368M |
| September 30, 2016 | 23.72M |
| June 30, 2016 | 23.16M |
| March 31, 2016 | 3.74M |
| December 31, 2015 | 4.739M |
| September 30, 2015 | 5.692M |
| June 30, 2015 | 6.625M |
| March 31, 2015 | 7.528M |
| December 31, 2014 | 8.402M |
| September 30, 2014 | 9.26M |
| June 30, 2014 | 10.08M |
| March 31, 2014 | 9.985M |
| December 31, 2013 | 9.892M |
| September 30, 2013 | 9.798M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
| Geron Corp | 82.74M |
| Immuneering Corp | -- |
| Protagonist Therapeutics Inc | 0.00 |
| Akebia Therapeutics Inc | 30.14M |
| Moderna Inc | 0.00 |